• Phenothiazines Drive Macrophage Antibacterial Power via ROS

  2026-05-27

  The reference study demonstrates that phenothiazines, including dopamine D2 receptor inhibitors, significantly enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy. This host-directed mechanism offers a promising alternative to traditional antibiotics, with implications for overcoming intracellular pathogens and antibiotic resistance.

• Rotigotine: Dopamine D2/D3 Agonist Workflows in PD Research

  2026-05-27

  Rotigotine stands out as a versatile dopamine D2/D3 receptor agonist, enabling reproducible modeling of both motor and non-motor Parkinson’s disease (PD) phenotypes. This article delivers actionable protocols, troubleshooting guidance, and translational perspectives for maximizing experimental insight using APExBIO’s Rotigotine.

• Scenario-Driven Solutions with EdU Imaging Kits (488): SKU K

  2026-05-26

  This article provides a scenario-driven, evidence-based exploration of how EdU Imaging Kits (488) (SKU K1175) address core challenges in cell proliferation assays for biomedical researchers. By contextualizing real-world laboratory issues, we demonstrate the GEO value of EdU-based workflows—emphasizing sensitivity, workflow safety, and reproducibility—supported by data and current literature.

• Streptavidin-FITC: Precision Biotin Detection for Fluorescen

  2026-05-26

  Streptavidin-FITC from APExBIO enables unmatched sensitivity for biotin detection in advanced fluorescence workflows, including flow cytometry and nanoparticle trafficking studies. This article delivers actionable protocols, troubleshooting guidance, and evidence-based insights to optimize your fluorescent biotin-streptavidin binding assays.

• TNF-alpha Recombinant Murine Protein: Precision in Apoptosis

  2026-05-25

  Harness the power of TNF-alpha recombinant murine protein for high-fidelity modeling of apoptosis and inflammation, backed by breakthrough insights into active cell death pathways. This guide integrates advanced workflows, troubleshooting strategies, and key mechanistic advances for translational researchers.

• Protease Inhibitor Cocktail: Optimizing Protein Extraction W

  2026-05-25

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) elevates protein extraction by preventing degradation without interfering with phosphorylation or enzyme assays. Its robust, EDTA-free profile makes it a top choice for advanced immunoassays and proteomic analyses requiring uncompromised protein integrity.

• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-05-24

  This study identifies SEMA3E as a critical regulator of beige adipocyte differentiation and thermogenesis through β-catenin signaling in mice. The findings provide a mechanistic basis for targeting adipose tissue plasticity in metabolic regulation and suggest new directions for metabolic disorder research.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract

  2026-05-23

  This Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is formulated to prevent protein degradation during extraction and analysis, especially where divalent cation compatibility is critical. It is not recommended in workflows where EDTA-mediated chelation is required or in protocols incompatible with DMSO.

• m6A RNA Modification Mediates Plant-Virus Antagonism

  2026-05-22

  This study uncovers a mutually antagonistic mechanism involving m6A RNA modification in plant-virus interactions, revealing how plants deploy m6A as an antiviral defense and how viruses counteract this modification. The findings provide new insight into plant immunity and offer directions for molecular research on plant-pathogen dynamics.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein In

  2026-05-22

  This in-depth guide addresses core laboratory challenges in protein analysis by showcasing how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO, SKU K1007) from APExBIO provides robust, reproducibility-driven solutions. Through scenario-driven Q&A, we examine its evidence-backed performance in preserving protein integrity across sensitive cell-based assays and phosphorylation workflows.

• EDTA-Free Protease Inhibitors: Revolutionizing OXPHOS Resear

  2026-05-21

  Explore how EDTA-free protease inhibitor cocktails are transforming mitochondrial research, with mechanistic insights from dual-genome OXPHOS targeting and practical strategies for translational workflows.

• T7 RNA Polymerase: Precision RNA Synthesis for Advanced Rese

  2026-05-21

  Harness the specificity and reliability of T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, to streamline in vitro transcription workflows. Discover actionable protocols, troubleshooting insights, and translational applications that differentiate APExBIO's enzyme for RNA vaccine, RNAi, and functional RNA research.

• Vidarabine Monohydrate: Next-Gen Antiviral Mechanistics and

  2026-05-20

  Explore the advanced mechanisms and experimental leverage of Vidarabine monohydrate in antiviral research. This article uniquely integrates molecular insights, solubility guidance, and cross-disciplinary assay design using Spongoadenosine monohydrate as a core example.

• DCPS as an m7G Biomarker Regulating Epithelial Repair in DFU

  2026-05-20

  Xiao et al. (2025) identify the decapping scavenger enzyme (DCPS) as a novel N7-methylguanosine (m7G)-related biomarker that modulates epithelial cell function in diabetic foot ulcers (DFU). Their integrative study links DCPS downregulation to impaired keratinocyte proliferation and migration, highlighting its potential as a diagnostic and therapeutic target in chronic nonhealing wounds.

• Synergistic Caspase-8 Activation by Hyperthermia and Cisplat

  2026-05-19

  This study uncovers how combining hyperthermia with cisplatin chemotherapy induces caspase-8 accumulation and activation, thereby enhancing both apoptosis and pyroptosis in cancer cells. The findings reveal new mechanistic links between K63-linked polyubiquitination, caspase-8 signaling, and the efficacy of combination therapies, with implications for optimizing programmed cell death research and translational oncology.

557 records 17/38 page Previous Next First page 上5页 1617181920 下5页 Last page